-
LBA73 The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:012020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology vaccines and immunoinformatics approaches Open access
Pia Kvistborg, Anastasia Gangaev, Steven L. C. Ketelaars, S. Patiweal, Anna Dopler, Olga I. Isaeva, +13 more
0citations -
861P Limited implementation of the ESMO-ESGO (European Society of Gynaecological Oncology)-ESTRO (European Society for Radiotherapy and Oncology) consensus conference recommendations (CCR) on endometrial cancer (EC)
Cristiana Sessa, Nicoletta Colombo, Carien L. Creutzberg, Nicole Concin, Pauline Wimberger, K.A. Marinoni, +3 more
0citations -
731P The impact of proton pump inhibitors on pazopanib exposure2020 Annals of Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Stefanie D. Krens, Floor J.E. Lubberman, Frank G. A. Jansman, David Marinus Burger, Paul Hamberg, Walter L. Vervenne, +4 more
0citations -
1449P Hospital volume and beyond first-line palliative systemic treatment administration in metastatic esophagogastric adenocarcinoma: A population-based study
Willemieke P.M. Dijksterhuis, Rob H.A. Verhoeven, Marieke Pape, Marije Slingerland, Nadia Haj Mohammad, Judith de Vos‐Geelen, +6 more
0citations -
1628MO A new benchmark for designing phase II trials for advanced or metastatic leiomyosarcoma (LMS) patients using progression free survival (PFS) as primary endpoint – an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis
Georgios Kantidakis, Saskia Litière, Anouk Neven, Marie Vinches, Ian Robert Judson, Patrick Schöffski, +7 more
0citations -
316P Implementation of Vela Analytics to accelerate comprehensive interpretation and reporting of next-generation sequencing-based oncology testing in clinical diagnostic laboratories2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access
Yin Yu, O. Scully, T. Zhang, Z.H. Kyaw, V.Y. Chung, Pramila Nuwantha Ariyaratne, +4 more
0citations -
1009P Current strategies of cell and gene therapy for solid tumors: Preliminary results of the joint international ESMO and EBMT Cell Therapy and Immunobiology Working Party questionnaire-based survey
P. Comoli, George E. Pentheroudakis, Paolo Pedrazzoli, Annalisa Ruggeri, Ulrike Koehl, Florian Lordick, +6 more
0citations -
685P Genome-wide association meta-analysis identifies novel variants that correlate with efficacy outcomes in sunitinib-treated patients with metastatic renal cell carcinoma
Meta H.M. Diekstra, Jesse Joachim Swen, L. van der Zanden, Epic Boven, Ron H.J. Mathijssen, Arna Óskarsdóttir, +13 more
0citations -
1081P Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients: Nation-wide quality assurance in the Netherlands
Jesper van Breeschoten, Alfons J.M. van den Eertwegh, Liesbeth C. de Wreede, Doranne L. Hilarius, Erik W. van Zwet, John B.A.G. Haanen, +14 more
0citations -
1506MO Incorporating genetic and non-genetic risk factors in breast cancer risk prediction for healthy women with non-informative genetic test result2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Anja Tüchler, Robert Remy, Julia Dick, Corinna Ernst, Britta Blümcke, Inge M. M. Lakeman, +6 more
0citations -
791MO Clinical and tumor characteristics of patients (pts) with recurrence after pathologic response upon neoadjuvant ipilimumab (IPI) + nivolumab (NIVO) in stage III melanoma
J.M. Versluis, Robert Elens, Irene L. M. Reijers, Alexander Maxwell Menzies, Astrid A.M. van der Veldt, E. Kapiteijn, +12 more
0citations -
860P The IOpener study: Tyrosine kinase activity in peripheral lymphocytes to predict durable response to immune checkpoint inhibition in patients with advanced melanoma
Karlijn de Joode, Karijn P.M. Suijkerbuijk, J.W.B. de Groot, Astrid A.M. van der Veldt, Hans M. Westgeest, Rik de Wijn, +12 more
0citations